Pan Medical Corporation, (www.panmed.us) specializing in the creation and development of cutting edge products, is glad to announce 510(k) approval for the InterV Flex and InterV Mico vertebral augmentation systems.
The InterV Flex is a curved needle and pre-curved balloon for use in vertebral augmentation procedures. The nitinol Flex needle is used to cross midline and create a void in the vertebral body as well as deliver cement. The first kyphoplasty pre-curved balloon unique to Pan Medical can then be inserted to follow the path created by the nitinol needle. In addition, Pan Medical is the first company to offer surgeons the unique option to use the new 510(k) cleared 13 gauge InterV Mico balloon catheter and insert this through the InterV Flex nitinol needle. Afterwards, the curved needle is then used as a curved cement delivery device. This technique is unique to Pan Medical.
Pan Medical has been working on balloon technology for nearly thirty years which is why they are able to offer features such as 13-gauge balloon, up to 750PSI balloon rating, and first kyphoplasty pre-curved balloon.
The InterV Mico is a true 13 gauge kyphoplasty product line with multiple configurations and options. For more information or distribution opportunities about the InterV Flex and InterV Micro please contact panmed@panmed.us
-What were one or two interesting moments/milestones during the development of each of these products?
Creating the InterV Micro was a challenge as we had to work with the rigidity of the shaft to pass through a true 13 gauge cannula. Through our years of balloon manufacturing experience we were able to implement our newest technology along with laser welding to extrude a thinner balloon wall to overcome this profile handicap.
A great milestone with the InterV Flex curved needle, is the ability for it to work in conjunction with the 13 gauge balloon creating the most precise, accurate and quickest atraumatic way to perform a kyphoplasty procedure. This single device creates a void, allows for balloon deployment and cement delivery.
-Where do you hope to “be” one year from now with these?
We continue to progress into the interventional radiology market with new products currently under under FDA review and continuing to make kyphoplasty a more minimally invasive procedure.
The views, opinions and positions expressed within these guest posts are those of the author alone and do not represent those of Becker's Hospital Review/Becker's Healthcare. The accuracy, completeness and validity of any statements made within this article are not guaranteed. We accept no liability for any errors, omissions or representations. The copyright of this content belongs to the author and any liability with regards to infringement of intellectual property rights remains with them.